The estimated Net Worth of Robert W. Mc Mahon is at least 6.9 百万$ dollars as of 4 November 2016. Mr. Mahon owns over 6,880 units of Agilent Technologies stock worth over 2,517,544$ and over the last 10 years he sold A stock worth over 0$. In addition, he makes 4,379,240$ as Chief Financial Officer、 Senior Vice President at Agilent Technologies.
Robert has made over 2 trades of the Agilent Technologies stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 6,880 units of A stock worth 954,256$ on 4 November 2016.
The largest trade he's ever made was exercising 7,346 units of Agilent Technologies stock on 26 May 2015 worth over 254,245$. On average, Robert trades about 323 units every 12 days since 2014. As of 4 November 2016 he still owns at least 18,151 units of Agilent Technologies stock.
You can see the complete history of Mr. Mahon stock trades at the bottom of the page.
Robert W. McMahon is Chief Financial Officer, Senior Vice President of the Company. He previously served as the Chief Financial Officer of Hologic, Inc., a medical technology company from May 2014 to August 2018. Prior to Hologic, Mr. McMahon spent 20 years with Johnson & Johnson most recently as Worldwide Vice President of Finance and Business Development for Ortho Clinical Diagnostics a division of Johnson & Johnson's Medical Device and Diagnostics Group.
As the Chief Financial Officer、 Senior Vice President of Agilent Technologies, the total compensation of Robert McMahon at Agilent Technologies is 4,379,240$. There are 1 executives at Agilent Technologies getting paid more, with Michael McMullen having the highest compensation of 12,520,600$.
Robert McMahon is 51, he's been the Chief Financial Officer、 Senior Vice President of Agilent Technologies since 2018. There are 19 older and 6 younger executives at Agilent Technologies. The oldest executive at Agilent Technologies Inc. is Tadataka Yamada, 75, who is the Independent Director.
Over the last 22 years, insiders at Agilent Technologies have traded over 170,735,833$ worth of Agilent Technologies stock and bought 25,786 units worth 823,096$ . The most active insiders traders include William P Sullivan、George A Scangos、Mikael Dolsten. On average, Agilent Technologies executives and independent directors trade stock every 20 days with the average trade being worth of 3,748,368$. The most recent stock trade was executed by Padraig Mcdonnell on 22 August 2024, trading 1,958 units of A stock currently worth 283,910$.
analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
Agilent Technologies executives and other stock owners filed with the SEC include: